Found 20 matching trials
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen PHASE2 The goal of this clinical study is to learn more about the effects of switc...
Show More Status
Active Not Recruiting
Location
Be Well Medical Center
Learn More & Join Trial
CCR5 Inhibitor Treatment Intensification on CD4+ T-cell Recovery PHASE4 CCTG 590 is a open-label study to evaluate the impact of therapy intensific...
Show More Location
University Southern California
Learn More & Join Trial
Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV PHASE1 The purpose of this study is to characterise the pharmacokinetic profiles o...
Show More Location
Germans Trias i Pujol Hospital
Learn More & Join Trial
Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American Participants PHASE3 The primary objective of this study is to evaluate the efficacy of switchin...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266) N/A This is a multi-center, longitudinal observational study of adult human imm...
Show More Location
Multiple Locations
Learn More & Join Trial
Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS) PHASE2 The purpose of this pilot study is to determine whether Maraviroc is effect...
Show More Location
San Francisco General Hospital, Clinical Trials Unit
Learn More & Join Trial
Effect of Cytoreductive Chemotherapy and a CCR5 Coreceptor Antagonist on HIV-1 Eradication EARLY_PHASE1 Effect on HIV-1 cell reservoirs of the concomitant administration of intens...
Show More Location
Hospital Universitario Ramon Y Cajal
Learn More & Join Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection N/A This study was designed to provide early access to and evaluate the safety ...
Show More Status
Approved For Marketing
Location
1182.70.127 Health Services Center, Inc.
Learn More & Join Trial
IMPAACT P1080: Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and Adolescents N/A The main purpose of this study is to find out how stimulant medications (me...
Show More Location
Univ. of Alabama Birmingham NICHD CRS (5096)
Learn More & Join Trial
Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients PHASE2 This is an open-label, randomized, parallel group pharmacokinetics trial of...
Show More Location
Boehringer Ingelheim Investigational Site
Learn More & Join Trial